Testing the Addition of Chemotherapy Drug, Cisplatin, to Usual Radiation Therapy for Patients with Head and Neck Cancer
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Head and Neck Cancer
Age: Between 18 - 100 Years
Gender: Male or Female
Individuals at least 18 years of age with squamous cell carcinoma of the head/neck, that has been surgically removed.
Individuals with recurrent disease or multiple primaries will not be eligible.
Women who are pregnant or breastfeeding will not be eligible.
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required